Drawing for REFUSE TO LOSE

USPTO serial 50144503

REFUSE TO LOSE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with REFUSE TO LOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua S. Jarvis, Esq.

Joshua S. Jarvis, Esq. Foley Hoag LLP155 Seaport BoulevardSeaport WestBoston, MA 02210-2600

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, neurological diseases and disorders, and ophthalmic diseases and disorders; Pharmaceutical preparations for the treatment of Guillain-Barré syndrome, macular degeneration, geographic atrophy, Huntington's Disease, amyotrophic lateral sclerosis (ALS), lupus, cold agglutinin disease (CAD), chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis (MG)ACTIVE—
042Pharmaceutical research and development; Consulting services in the field of pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trialsACTIVE—
044Providing medical information; Providing medical information in the field of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 5, 2026NWAPNEW APPLICATION ENTERED—
Oct 5, 2026MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance